When was Exela Pharma founded?

Exela Pharma was founded in 2005 and raised its 1st funding round 3 years after it was founded.

Where is Exela Pharma located?

Exela Pharma is headquartered in Lenoir, United States. It is registered at Lenoir, North Carolina.

Who is the current CEO of Exela Pharma?

Phanesh Koneru and Phanesh Koneru s of Exela Pharma. Phanesh Koneru has also founded 1 company.

How many employees does Exela Pharma have?

As of Jun 30, 2026, the latest employee count at Exela Pharma is 339.

Is Exela Pharma a funded company?

Exela Pharma is a funded company, having raised a total of $6.67M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2008.

When was the latest funding round of Exela Pharma?

Exela Pharma's latest funding was a $***** Grant (prize money) round on Sep 25, 2025, with participation from 1 investor.

Where does Exela Pharma rank among its competitors?

Exela Pharma ranks 10th amongst 103 active competitors, of which 9 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Exela Pharma, which secured $28.3M in Sep, 2025.

Who are the top competitors of Exela Pharma?

Exela Pharma's top competitors include Luoxin Pharmaceutical Group, INCOG BioPharma Services and Gland Pharma. Among them, Exela Pharma secured the most recent funding round in September, 2025.

Exela Pharma - 2026 Company Profile, Team, Funding & Competitors

Exela Pharma is a series B company based in Lenoir (United States), founded in 2005 by Phanesh Koneru and Phanesh Koneru. It operates as a Manufacturer of sterile injectable pharmaceutical products and CDMO services. Exela Pharma has raised $6.67M in funding. The company has 103 active competitors, including 9 funded and 24 that have exited. Its top competitors include companies like Luoxin Pharmaceutical Group, INCOG BioPharma Services and Gland Pharma.

Company Details

Manufacturer of sterile injectable pharmaceutical products and CDMO services. This entity develops and manufactures both proprietary and generic sterile injectables. Its operations encompass the entire pharmaceutical lifecycle, from research and development to finished drug product manufacturing and distribution. Services include contract development and manufacturing, leveraging expertise in liquid vials, IV bags, lyophilized vials, and pre-filled syringes. The company also offers a range of regulatory support services.

Website: exelapharma.com
Registered Address: Lenoir, North Carolina

Key Metrics

Founded Year

2005

Location

Lenoir, United States

Stage

Series B

Total Funding

$6.67M in 5 rounds

Latest Funding Round

Grant (prize money), Sep 25, 2025, $*****

Investors

Trinity Capital & 4 more

Ranked

10^th among 103 active competitors

Employee Count

339 as on Jun 30, 2026

Similar Companies

Luoxin Pharmaceutical Group & 116 more

View Exela Pharma's full profile

Exela Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Exela Pharma Sciences Llc CIN: 262756751 , United States, Active	Dec 31, 1999	-	433 (As on Dec 31, 2024)	-

Exela Pharma has raised a total funding of $6.67M over 5 rounds. Its first funding round was on 2008. Its latest funding round was a Grant (prize money) round on Sep 25, 2025 for $*****. 1 investor participated in its latest round. Exela Pharma has 5 institutional investors.

Here is the list of recent funding rounds of Exela Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 25, 2025	9832551	Grant (prize money)	2736412	9010736	3868357	9827940
Sep 08, 2021	3803664	Series B	4635865	2944678	3256951	Premier
Aug 24, 2015	3727515	Series A	5284784	2148826	9402668	5570497

Access funding benchmarks and valuations. Sign up today!

View details of Exela Pharma's funding rounds and investors

The founders of Exela Pharma are Phanesh Koneru and Phanesh Koneru. Phanesh Koneru is the CEO of Exela Pharma.

Here are the details of Exela Pharma's key team members:

Phanesh Koneru: Founder & CEO of Exela Pharma.
Phanesh Koneru: Co-Founder & CEO of Exela Pharma.

View details of Exela Pharma's Founder profiles and Board Members

Exela Pharma's employee count trend

Exela Pharma has 339 employees as of Jun 26. Here is Exela Pharma's employee count trend over the years:

Uncover Exela Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Exela Pharma include Luoxin Pharmaceutical Group, INCOG BioPharma Services and Gland Pharma. Here is the list of Top 10 competitors of Exela Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Luoxin Pharmaceutical Group 2006, Linyi (China), Acquired	Developer and manufacturer of pharmaceutical products	$301M	Ennovation Ventures, Yuanchuang Duoying Investment Group ... Read more	61/100
2nd	INCOG BioPharma Services 2020, United States, Series C	CDMO focused on manufacturer of injectable drug product	$86.6M	-	54/100
3rd	Gland Pharma 1978, Hyderabad (India), Public	Manufacturer of generic injectable drug	$209M	KKR, Markandaya Discretionary Trust & 59 others	54/100
4th	ApiJect 2015, Stamford (United States), Series D	Manufacturer of medicine injectors	$111M	Jefferies, Royalty Pharma & 2 others	54/100
5th	Vetter Pharma 1950, Ravensburg (Germany), Funding Raised	CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.	-	Commerzbank, Deutsche Bank & 1 others	47/100
6th	American Regent 1967, Shirley (United States), Unfunded	Pharmaceutical company providing essential medicines and improving patient and animal lives	-	-	45/100
7th	ANG Lifesciences 2006, Amritsar (India), Public	CMO specializing in Dry Powder Injectables (SVPs)	-	-	44/100
8th	Avenacy 2023, Schaumburg (United States), Series B	Specialty pharmaceutical company focused on developing and manufacturing critical medications.	$26M	-	44/100
9th	Torbay Pharmaceuticals 1975, Paignton (United Kingdom), Acquired	Provider of sterile injectable drugs and pharmaceutical manufacturing services	-	-	43/100
10th	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Baruch Future Ventures & 3 others	43/100